Cardiologists have found a way to cool the human heart in a localized way to help reduce muscle damage from heart attacks. 

A cholesterol-lowering drug significantly cut the risk of heart attack and stroke in a recent study. But is it worth the steep cost?

The genomics arm of the National Institutes of Health has pledged a total of $280 million for research into the genetic bases of disease.

Genetic variants that cripple a triglyceride-producing protein are linked with a lower risk of heart attack and stroke.

In the latest iteration of organ-on-a-chip technology, researchers develop an in vitro model of functioning human heart tissue with an inherited cardiovascular disease.

A report reveals that using bone marrow stem cells to treat heart disease is less promising than a decade of research has let on.

Nanoscale agents that detect disease-associated synthetic biomarkers in urine could one day streamline the diagnosis of tumors, heart disease, and more.

A genetic mapping study of intestinal bacteria shows that people with fewer and less diverse bacteria are at greater risk of obesity and associated diseases.

From cardiovascular problems to neurological disorders, a plethora of new medical devices are reducing the need for surgery and improving the quality and safety of healthcare.

Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.